Table 4.
Brain-specific proteins
| AMS– (n= 9) | AMS+ (n= 9) | |||||
|---|---|---|---|---|---|---|
| GROUP: | ||||||
| CONDITION: | Normoxia | Hypoxia | Δ | Normoxia | Hypoxia | Δ |
| S100β (μg l−1) | 0.04 ± 0.03 | 0.05 ± 0.05 | 0.01 ± 0.05 | 0.03 ± 0.04 | 0.06 ± 0.07 | 0.03 ± 0.04 |
| NSE (μg l−1) | 5.4 ± 1.2 | 4.9 ± 0.9 | −0.5 ± 0.09 | 4.8 ± 1.1 | 4.6 ± 0.6 | −0.2 ± 0.9 |
Values are mean ±s.d.; subjects without (AMS–) and with (AMS+) acute mountain sickness; NSE, neuron specific enolase; Δ, delta value (hypoxia minus normoxia); no main effects observed (P > 0.05) for group (pooled normoxia + hypoxia) difference between AMS–versus AMS+ or condition (pooled AMS–+ AMS+) difference between normoxia versus hypoxia.